Literature DB >> 27637756

Discretely Integrated Condition Event Simulation for Pharmacoeconomics.

Mondher Toumi1,2, Ekkehard Beck3, Steve Sherman4, Leyla Mohseninejad5, Samuel Aballéa1,2.   

Abstract

Mesh：

Year:  2016        PMID： 27637756     DOI： 10.1007/s40273-016-0449-1

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  5 in total

1.  Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1.

Authors:  J Jaime Caro; Andrew H Briggs; Uwe Siebert; Karen M Kuntz
Journal:  Value Health       Date:  2012 Sep-Oct       Impact factor: 5.725

2.  State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3.

Authors:  Uwe Siebert; Oguzhan Alagoz; Ahmed M Bayoumi; Beate Jahn; Douglas K Owens; David J Cohen; Karen M Kuntz
Journal:  Med Decis Making       Date:  2012 Sep-Oct       Impact factor: 2.583

3.  Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--4.

Authors:  Jonathan Karnon; James Stahl; Alan Brennan; J Jaime Caro; Javier Mar; Jörgen Möller
Journal:  Value Health       Date:  2012 Sep-Oct       Impact factor: 5.725

Review 4.  When to use discrete event simulation (DES) for the economic evaluation of health technologies? A review and critique of the costs and benefits of DES.

Authors:  Jonathan Karnon; Hossein Haji Ali Afzali
Journal:  Pharmacoeconomics       Date:  2014-06       Impact factor: 4.981

5.  Discretely Integrated Condition Event (DICE) Simulation for Pharmacoeconomics.

Authors:  J Jaime Caro
Journal:  Pharmacoeconomics       Date:  2016-07       Impact factor: 4.981
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.